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Transcatheter Aortic Valve in Valve Implantation Through a
Prosthesis Carotid Artery: First Case
HANANE BENHALLA AND CAMELIA SOREA
From Brussels Heart Center, Brussels, Belgium
BENHALLA AND SOREA: Transcatheter Aortic Valve in Valve Implantation Through a Prosthesis Carotid
Artery: First Case: In recent years, transcatheter aortic valve implantation has become an emerging alternative for
high-risk patients with severe aortic stenosis. We report a case of transcatheter aortic valve implantation with the
self-expanding Medtronic CoreValve bioprosthesis through a left common carotid artery. This 83-year-old male
patient presented with heart failure due to a severe degenerative aortic bioprosthesis, with several comorbidities,
resulting in a logistic EuroScore II of 36%. Consequently, he was rejected to undergo surgery and a transcatheter
approach was planned. And due to severe peripheral vascular disease with iliofemoral lesions, significant calcifications
of the innominate artery, we considered a left carotid access through a prosthesis carotid in Dacron. The procedure
was successful without cardiac, cerebrovascular, or access complications. And it appears to be a valuable alternative
access for patients with severe peripheral vascular disease. (J HK Coll Cardiol 2015;23:6-9)
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Introduction
The first percutaneous aortic valve replacement
has been performed by Dr. A. Cribier in 2002, opening
a new therapeutic approach to patients at high surgical
risk for conventional operation by sternostomy.
Within a short time, there has been an
improvement of the material and a simplification of the
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procedure, the surgical approach used and the
implantation technique. However patient selection
remains crucial. We describe a percutaneous aortic
valve implantation (a CoreValve bioprosthesis) in a
degenerated bioprosthesis without an adequate vascular
access, and which we decide to add prosthesis carotid
in Dacron in per operative procedure.
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An 83-year-old male, presented with heart failure
due to a severe degenerative aortic bioprosthesis
operated in 2009, with comorbidities included diabetes,
hypertension, chronic pulmonary obstructive disease,
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as well as peripheral and coronary artery disease,
resulting in a logistic EuroScore II of 36%.
Preinterventional morphological patient screening
included transthoracic as well as transesophageal
echocardiography, confirmed a severely calcified aortic
bioprosthesis with a mean transprosthesis gradient of
53 mmHg, valve area 0.8 cm2, and ejection fraction of
40%.
Computed tomographic illustrate showed a
peripheral vascular disease with iliofemoral lesions,
the diameter of the common iliac artery was of 5 mm
and the subclavian arteries were about 5-6 mm with
significant calcifications and unfavourable
angulations of the innominate artery. Therefore, we
considered a left carotid access, with a diameter of
6.5 mm, as the only solution with the use of a
prosthesis carotid in Dacron to facilitate the
procedure. The aortic annulus diameter, and the
distance of the coronary ostia were also evaluated.
The carotid artery was first reopened under
local anaesthesia and then after intubation and
induction of general anaesthesia, endarterectomy of
the left carotid artery was performed. Thereafter, an
8 mm Dacron prosthesis was connected to the left
common carotid artery in an end-to-side fashion and
a sheath was introduced into it. Via this approach, a
self-expanding aortic valve prosthesis (CoreValve,
Medtronic) was placed in typical position but 4 mm
below (Figures 1 & 2). Importantly, the introducer
sheath was not advanced into the carotid artery, so
that antegrade blood flow was maintained during the
entire TAVI procedure without further shunting. A
localization 4 mm below the position is considered
ideal for implantation. In this case (Figure 3) this
may explain the immediate postoperative transaortic
prosthesis mean gradient of 20 mmHg ,with aortic
prosthesis area of 1.1 cm2.
In the Post-operative follow up there is an
important improvement of signs of heart failure
within the first week for the patient.
The patient was seen one month after
the procedure with a clear clinical improvement
and regression of his episodes of cardiac
decompensation.
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Discussion
The entry in our case of the right native carotid
artery was facilitated by the introduction of a prosthesis
carotid in Dacron. The advantages of this procedure,
are an optimal neuromonitoring during the carotid
surgery in local anaesthesia and a simple implantation
of the catheter-based aortic valve prosthesis via the same

Figure 1. Computed tomographic viewing the aortic
prosthetic ring with calcifications before and after the
endovalve implantation.
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Figure 3. Computed tomographic view of the percutaneous
valve relative to the ring of the degenerated bioprosthesis.

Figure 2. Angiographic view of the introduction of the
percutaneous aortic valve on the degenerated bioprosthesis
and the result seen in the chest radiograph.
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access and during an only short period of general
anaesthesia. Importantly, as already mentioned above,
the introducing sheath for the TAVI must only be
advanced into the "Dacron chimney" and not further
into the carotid artery to provide a sufficient antegrade
flow throughout the whole procedure.1,2
Very limited experience exists with surgical
access via the carotid artery. In a small series reported
by Modine et al of 12 patients, the procedure was
successful in all. There was no mortality, but 1 patient
had a stroke , which mean that electroencephalogram
monitoring in parallel to the procedure seems necessary
to monitor cerebral perfusion.3
The median time for the implantation of the valve
in valve is about 120 minutes in the European register.3
For our case, it was 180 minutes with a fluoroscopy
time of 36 minutes. This was explained by the initial
implantation of the Dacron prosthesis.
For the valve in valve procedure the most
common risk is the less optimal deployment of the
percutaneous valve, secondary to calcifications
usually present on the bioprosthesis especially if it
is asymmetric, 3 Correct sizing is paramount, as
undersizing may increase the risk of paravalvular
regurgitation or valve migration whereas oversizing
may lead to leaflet distortion within the transcatheter
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heart valve, There is also often the need to implant a
permanent pacemaker (5.7% to 20% for Corvalve)
which remains the most common event described in
the first 30 days with a positioning 2 to 6 mm
below the base of the aortic annulus, which may
interfere with the atrioventricular node, located very
close to the aortic region and sub-membranous
septum.3,4

Conclusion
The common carotid access has been
demonstrated to be a feasible and safe access route
for TAVI. It appears to be a valuable alternative access
for patients who cannot undergo trans-femoral TAVI,
to expand the benefit from this technology with less
bleeding events, less access-related complications
and immediate patient ambulation.
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